{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:33:08Z","timestamp":1764401588095},"reference-count":22,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.vaccine.2012.07.034","type":"journal-article","created":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T04:30:46Z","timestamp":1343190646000},"page":"5967-5972","source":"Crossref","is-referenced-by-count":21,"title":["Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK\u00aeV) in children"],"prefix":"10.1016","volume":"30","author":[{"given":"Kenji","family":"Okada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Iwasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Namazue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masateru","family":"Akechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeharu","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.07.034_bib0005","series-title":"Vaccines","first-page":"311","article-title":"Japanese encephalitis vaccines","author":"Halstead","year":"2008"},{"key":"10.1016\/j.vaccine.2012.07.034_bib0010","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJMp058263","article-title":"Control of Japanese encephalitis \u2013 within our grasp?","volume":"355","author":"Solomon","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.07.034_bib0015","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3201\/eid1209.060200","article-title":"Japanese encephalitis outbreak, India, 2005","volume":"12","author":"Parida","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2012.07.034_bib0020","first-page":"331","volume":"81","author":"WHO","year":"2006","journal-title":"Wkly Epidemiol Record"},{"key":"10.1016\/j.vaccine.2012.07.034_bib0025","doi-asserted-by":"crossref","first-page":"704","DOI":"10.4269\/ajtmh.2003.68.704","article-title":"Acute undifferentiated fever caused by infection with Japanese encephalitis virus","volume":"68","author":"Watt","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.07.034_bib0030","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/infdis\/161.5.878","article-title":"Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants","volume":"161","author":"Poland","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.07.034_bib0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1442-200X.1988.tb02516.x","article-title":"Japanese encephalitis vaccine","volume":"30","author":"Oya","year":"1988","journal-title":"Acta Paediatr Jpn"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2012.07.034_bib0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0264-410X(00)00041-4","article-title":"Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains","volume":"18","author":"Kurane","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.07.034_bib0045","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0264-410X(87)90059-4","article-title":"Effect of current Japanese encephalitis vaccine on different strains of Japanese encephalitis virus","volume":"5","author":"Okuno","year":"1987","journal-title":"Vaccine"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2012.07.034_bib0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0264-410X(00)00039-6","article-title":"Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus","volume":"18","author":"Tsarev","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.07.034_bib0055","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/S0264-410X(00)00111-0","article-title":"Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States","volume":"18","author":"Takahashi","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.07.034_bib0060","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0264-410X(02)00772-7","article-title":"Establishment of an analyzing method for a Japanese encephalitis virus neutralization test in Vero cells","volume":"21","author":"Abe","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.07.034_bib0065","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1016\/j.vaccine.2011.06.062","article-title":"Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO\u00ae) induced neutralizing antibody titers","volume":"29","author":"Gessel","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.07.034_bib0070","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1056\/NEJM198809083191004","article-title":"Protection against Japanese encephalitis by inactivated vaccines","volume":"319","author":"Hoke","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.07.034_bib0075","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0140-6736(01)05967-0","article-title":"Efficacy of single-dose SA14-14-2 vaccine against Japanese encephalitis: a case control study","volume":"358","author":"Bista","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.07.034_bib0080","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1086\/517323","article-title":"Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects","volume":"176","author":"Liu","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.07.034_bib0085","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(05)67567-8","article-title":"Effect of single dose of SA14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study","volume":"366","author":"Ohrr","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.07.034_bib0090","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(07)61780-2","article-title":"Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial","volume":"370","author":"Tauber","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.07.034_bib0095","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/590116","article-title":"Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine","volume":"198","author":"Tauber","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.07.034_bib0100","unstructured":"CDC. Inactivated Japanese encephalitis virus vaccine recommendations of the advisory committee on immunization practices (ACIP). http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/00020599.htm [accessed September 12, 2007]."},{"key":"10.1016\/j.vaccine.2012.07.034_bib0105","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1016\/j.vaccine.2008.05.081","article-title":"Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 six and 12 month results of a multicenter follow-up phase 3 study","volume":"26","author":"Schuller","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.07.034_bib0110","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.vaccine.2009.10.024","article-title":"Immunogenicity and safety of IXIARO (IC51) in a phase II study in healthy Indian children between 1 and 3 years of age","volume":"28","author":"Kaltenb\u00f6ck","year":"2010","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1201047X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1201047X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T17:01:44Z","timestamp":1562000504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1201047X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":22,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0264410X1201047X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.07.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}